Ineos Bio names AMEC as global license support engineering firm to optimize waste-to-bioenergy technology for each site location

Tracy McDonald

Tracy McDonald

ROLLE, Switzerland, and ATLANTA , November 9, 2011 (press release) – -- INEOS Bio will license its advanced waste-to-bioenergy technology process globally.

-- INEOS Bio selected AMEC to be its global license support engineering firm as it rolls out its licensing program for its advanced bioenergy technology.

-- "This agreement is a key milestone for INEOS Bio. It is a crucial step as we move into the phase of licensing our Bioenergy Technology globally to help solve to address the world's waste management challenges," said Peter Williams, CEO of INEOS Bio.

INEOS Bio (www.ineosbio.com) today announced it has selected AMEC (www.amec.com), an international engineering company, to be its global license support engineering firm, as the company rolls out its licensing program for the INEOS Bio advanced bioenergy technology. AMEC will work with INEOS Bio in developing engineering design packages for future INEOS Bio technology licensees. In this role, AMEC will ensure the engineering designs for bioenergy facilities using INEOS Bio's advanced waste-to-bioenergy technology are optimized and customized for each site location. AMEC was selected following an extensive evaluation process of qualified global engineering firms.

The value of the contract has not been announced.

"This agreement is a key milestone for INEOS Bio. It is a crucial step as we move into the phase of licensing our Bioenergy Technology globally to help solve to address the world's waste management challenges," said Peter Williams, CEO of INEOS Bio. "We've designed our sustainable solution so it's easily licensed and can be replicated around the world to create renewable bioenergy from waste, bringing us energy independence and providing opportunities for cleantech jobs."

AMEC is one of the world's leading international engineering, procurement and construction management firms with deep expertise in the clean energy, environment and infrastructure markets. AMEC's experience in similar markets, along with its dedication to sustainable business practices makes it an ideal license support contractor for INEOS Bio. The two companies are currently working together on the first commercial-scale facility to deploy this advanced waste-to-bioenergy technology. Slated to come online in Q2 2012, the Indian River BioEnergy Center in Vero Beach, Florida will produce eight million gallons of advanced cellulosic ethanol and six megawatts (gross) of renewable power, while providing a solution for dealing with waste that would normally end up in a landfill.

"We are pleased INEOS Bio selected AMEC to handle the engineering designs of its waste-to-bioenergy technology," said Neil Bruce, AMEC's Chief Operating Officer "We are proud of our continued relationship with INEOS and believe our experience working with advanced bioprocesses and our first-hand understanding of the INEOS Bio technology will benefit future licensees."

INEOS Bio will strategically license its advanced bioenergy technology globally, while capitalizing on decades of licensing experience from its parent company, INEOS, and its global businesses. As the leading licensor of chemical process technology, INEOS currently has over 270 licenses for its technologies in 51 countries around the world. INEOS Bio will utilize a similar approach and leverage its skills, experience and resources to replicate this leading technology on a global basis. For more information about licensing the INEOS Bio waste-to-bioenergy technology, please contact Mark Dietzen at bioinfo@ineos.com.

Note to Editors

INEOS Bio is a Bioenergy company commercializing and licensing its novel thermochemical and bio-chemical technology for the production of renewable biofuels and renewable energy from a wide range of low-cost carbon materials. The company's initial focus is the commercialization of the world's leading third-generation ethanol technology process to serve the global renewable fuels and the renewable energy markets. INEOS Bio is one of the global businesses in INEOS. See www.ineosbio.com.

INEOS is the world's fourth largest chemicals group and a leading manufacturer of petrochemicals, specialty chemicals and oil products. As of the end of 2010, it operates 15 businesses and with a production network spanning 61 manufacturing facilities in 13 countries, the group produces more than 40 million tonnes of petrochemicals and 20 million tonnes per annum of crude oil refined products (fuels) each year. INEOS employs 15,000 people globally including over 3,000 people in the United States. It has annual sales of around $40bn. See www.ineos.com.

AMEC

AMEC (LSE: AMEC) is a focused supplier of consultancy, engineering and project management services to its customers in the world's oil and gas, minerals and metals, clean energy, environment and infrastructure markets. With annual revenues of around 3 billion pounds Sterling (US$4.5 billion), AMEC designs, delivers and maintains strategic and complex assets and employs some 27,000 people in around 40 countries worldwide. See amec.com.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

Share:

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.